Botanical species · safety record

Fraxinus chinensis

The EFSA Compendium of Botanicals holds 4 constituent measurements for Fraxinus chinensis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Fraxinus chinensis Roxb.

4Constituent measurements

0Safety records

4Cited sources

32Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 32 licensed products naming Fraxinus chinensis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Bark
Stem bark

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Coumarins	Bark	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Esculetin	Unspecified	Solvent extraction	—	—	Resolve DOI
Eleutheroside b	Bark	—	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Lignans	Bark	—	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Zhang, Dong-Mei., Wang, Li-Li., Li, Jia., Hu, Li-Hong. Two new coumarins from Fraxinus chinensis Rexb.. JOURNAL OF INTEGRATIVE PLANT BIOLOGY, 2007, vol. 49, no. 2, p. 218-221. DOI
Mukherjee, P.K., Maity, N., Nema, N.K., Sarkar, B.K. Bioactive compounds from natural resources against skin aging. Phytomedicine, 2011, vol. 19, no. 1, p. 64-73. DOI
Zhang, Dong-Mei., Hu, Li-Hong., Ye, Wen-Cai., Zhao, Shou-Xun. Studies on the chemical constituents of Fraxinus chinensis Roxb. Zhongguo tianran yaowu, 2003, p. 79-81.
Wei Xiu-Li., Yang Chun-Hua., Liang Jing-Yu. Constituents of the barks of Fraxinus chinensis Roxb.. Chinese journal of natural medicines, 2005, vol. 3, no. 4, p. 228-230.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature